Top Markets
#1 ADO Protocol ADO Protocol +193.44%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +43.47%
#4 GAIB AID GAIB AID +24.67%
#5 Casper Network Casper Network +15.03%
#6 Verus Coin Verus Coin +13.64%
#7 SkyAI SkyAI +13.54%
#8 Starpower Starpower +12.35%
#9 o1.exchange o1.exchange +11.59%
#10 Ontology Gas Ontology Gas +10.82%
Coin of the day
ADO Protocol ADO Protocol
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Peringkat dalam Saham #33498
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Harga Saham
$1.12
Terakhir disinkronkan: 2026-08-14
Kapitalisasi Pasar
$7.52M
Perubahan (1 hari)
4.51%
Perubahan (1 tahun)
-94.79%
Negara
US
Perdagangan NeoImmuneTech, Inc. (950220)

Kategori

Healthcare
Riwayat hasil dividen untuk NeoImmuneTech, Inc. (950220)
Hasil dividen (TTM) dari NeoImmuneTech, Inc. (simbol saham: 950220) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk NeoImmuneTech, Inc. (950220) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE